Expert Interviews
Robert E. Merritt, MD, MBA, FACS, discusses the analysis he presented at the IASLC 2024 World Conference on Lung Cancer.
Dr. Sadie Dobrozsi spoke on the importance of genetic testing in breast cancer to better understand the disease.
The renowned Dr. Emanuel Mignot spoke about the importance of personalized care for persons living with narcolepsy.
Shirish M. Gadgeel, MD, discusses the phase 1/2 ARROS-1 and ALKOVE-1 studies presented at the ESMO 2024 Congress.
Dr. Sanjeev Kothare spoke about recent advancements, as well as challenges in narcolepsy care.
Dr. Michael Strunc speaks about recent advancements in narcolepsy care, and treatment gaps that still need to be filled.
Richard Kim of Avadel talks about the "exciting" future of narcolepsy care.
Théophile Mohr-Durdez, CEO and co-founder of Volta Medical, talks about streamlining workflows for electrophysiologists.
Dr. Kiran Maski was presented with the Research Pioneer Award at the WUN Shadows to Light gala.
Jennifer Gudeman talks about the significance of the WUN Shadows to Light gala and role Avadel plays in treating narcolepsy.
The real-world study was presented at the IASLC 2024 World Conference on Lung Cancer.
Michael Spigler of the American Kidney Fund spoke with Nephrology Times about the Unknown Causes of Kidney Disease Project.
Dr. Rolfo discusses results of an analysis that evaluated the impact of BMI on TTFields therapy.
Dr. Morse provided her thoughts on both hosting an informative panel, and on winning a prestigious award.
Mia Grisco talks about her narcolepsy journey, and how she thrives amid her diagnosis.
Dr. Leighl explains PALOMA-3 data presented at the IASLC 2024 World Conference on Lung Cancer.
The trial is investigating nogapendekin alfa inbakicept-pmln in combination with immune checkpoint inhibitor therapy.
Drs. Karine Tawagi and Adam Brufsky discuss exciting advancements and therapies on the horizon in the space of TNBC.
Dr. Adam Brufsky speaks with Dr. Adam Brufsky about the optimal therapeutic options to use in the TNBC patient population.
Drs. Karine Tawagi and Adam Brufsky discuss the biggest current challenges in the TNBC space.
The trial is evaluating perioperative pembrolizumab plus sacituzumab govitecan for certain patients with NSCLC.
Advertisement
Advertisement
